Drawing for WE ARE AUGMENT

USPTO serial 87104489

WE ARE AUGMENT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
YOO, JEANE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WE ARE AUGMENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christiane S. Campbell

CHRISTIANE S. CAMPBELL DUANE MORRIS LLP30 S 17TH ST FL 5PHILADELPHIA, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biological bone tissue for subsequent human implantation; implantable scaffolds comprising living tissue for soft tissue regeneration and repair therapy, namely, animal derma in the nature of acellular peritoneum replacement scaffold derived from biological tissue grafts for human implantation for the repair of rotator cuffs, patellar and Achilles tendons, biceps, quadriceps, personal and posteriorly tibial tendons, and other tendons; surgical implants comprising living tissue, namely, demineralized bone tissue and/or meson stem cells for bone treatment via subsequent implantationACTIVE—
041Providing education courses in the fields of medicine and technology; Educational services, namely, providing a learning and innovation center featuring instruction and training in the fields of medicine and technologyACTIVE—
044Providing medical information in the field of implantation, reconstructive, and joint replacement surgery; medical services, namely, providing medical information and advisory services related to use of particular surgical procedures and surgical tools therefor; providing an Internet accessible database for surgeons to input postoperative data for use in reporting said data to medical personnel for medical diagnostic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 13, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 13, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 28, 2019EX2GSOU EXTENSION 2 GRANTED—
Jan 25, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 14, 2018NREVNOTICE OF REVIVAL - E-MAILED—
Nov 13, 2018TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Nov 13, 2018PETGPETITION TO REVIVE-GRANTED—
Nov 13, 2018PROATEAS PETITION TO REVIVE RECEIVED—
Nov 13, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 12, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 10, 2018EXT2SOU EXTENSION 2 FILED—
Apr 7, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 5, 2018EX1GSOU EXTENSION 1 GRANTED—
Apr 5, 2018EXT1SOU EXTENSION 1 FILED—
Apr 5, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 10, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 15, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 27, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2017ALIEASSIGNED TO LIE—
May 24, 2017ALIEASSIGNED TO LIE—
May 8, 2017DOCKASSIGNED TO EXAMINER—
May 1, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 1, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 1, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Nov 1, 2016CNSLSUSPENSION LETTER WRITTEN—
Oct 25, 2016DOCKASSIGNED TO EXAMINER—
Jul 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 18, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance